Nov 7 (Reuters) - IMV Inc IMV.TO :
* NAVIDEA BIOPHARMACEUTICALS ANNOUNCES PRECLINICAL THERAPEUTIC RESEARCH COLLABORATION WITH IMV INC. TO EXPLORE THE POTENTIAL COMBINATORY EFFECT WITH THEIR PLATFORM-BASED IMMUNOTHERAPIES
* NAVIDEA BIOPHARMACEUTICALS INC - ENTERED A PRECLINICAL RESEARCH COLLABORATION TO EXPLORE POTENTIAL COMBINATORY EFFECT OF THEIR PLATFORM-BASED IMMUNOTHERAPIES